Ascendis Pharma A/S ADR (NASDAQ: ASND) on Tuesday, plunged -5.06% from the previous trading day, before settling in for the closing price of $207.12. Within the past 52 weeks, ASND’s price has moved between $118.03 and $223.18.
A company in the Healthcare sector has dropped its sales by -6.13% annually for the last half of the decade. The company achieved an average annual earnings per share of 49.83%. With a float of $60.47 million, this company’s outstanding shares have now reached $61.10 million.
Ascendis Pharma A/S ADR (ASND) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Ascendis Pharma A/S ADR is 1.03%, while institutional ownership is 104.71%. The most recent insider transaction that took place on Dec 04 ’25, was worth 2,081,019. Before that another transaction happened on Dec 02 ’25, when Company’s CEO proposed sale 100,000 for $210.85, making the entire transaction worth $21,085,000.
Ascendis Pharma A/S ADR (ASND) Performance Highlights and Predictions
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.64 earnings per share (EPS) for the period topping the consensus outlook (set at -0.93) by 0.29. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.39 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 49.83% per share during the next fiscal year.
Ascendis Pharma A/S ADR (NASDAQ: ASND) Trading Performance Indicators
Ascendis Pharma A/S ADR (ASND) is currently performing well based on its current performance indicators. A quick ratio of 0.73 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 16.67.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.25, a number that is poised to hit -0.12 in the next quarter and is forecasted to reach 4.31 in one year’s time.
Technical Analysis of Ascendis Pharma A/S ADR (ASND)
Let’s dig in a bit further. During the last 5-days, its volume was 0.63 million. That was better than the volume of 0.49 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 27.78%.
During the past 100 days, Ascendis Pharma A/S ADR’s (ASND) raw stochastic average was set at 57.39%, which indicates a significant increase from 4.33% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 8.45 in the past 14 days, which was higher than the 7.58 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $205.66, while its 200-day Moving Average is $180.07. However, in the short run, Ascendis Pharma A/S ADR’s stock first resistance to watch stands at $205.81. Second resistance stands at $214.98. The third major resistance level sits at $220.07. If the price goes on to break the first support level at $191.55, it is likely to go to the next support level at $186.46. Assuming the price breaks the second support level, the third support level stands at $177.29.
Ascendis Pharma A/S ADR (NASDAQ: ASND) Key Stats
Market capitalization of the company is 12.01 billion based on 61,695K outstanding shares. Right now, sales total 393,500 K and income totals -409,120 K. The company made 249,720 K in profit during its latest quarter, and -71,290 K in sales during its previous quarter.
